1-methoxy-2-(chloromethyl)naphthalene | 150714-52-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 1-methoxy-2-(chloromethyl)naphthalene
• 英文别名: 2-(Chloromethyl)-1-methoxynaphthalene
• CAS: 150714-52-6
• 化学式: C₁₂H₁₁ClO
• 分子量: 206.672
• InChiKey: IRSWPNROGCRRNG-UHFFFAOYSA-N

物化性质

• 沸点：
  328.2±17.0 °C(Predicted)
• 密度：
  1.179±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-methoxy-2-(chloromethyl)naphthalene 在 盐酸羟胺 、 sodium methylate 作用下， 以 甲醇 、 水 、 二甲基亚砜 、 乙腈 为溶剂， 反应 20.5h， 生成 N-Hydroxy-2-(1-methoxy-naphthalen-2-yl)-acetamidine
  参考文献：
  名称：

  Antihyperglycemic activity of novel naphthalenylmethyl-3H-1,2,3,5-oxathiadiazole 2-oxides

  摘要：

  A series of naphthalenyl 3H-1,2,3,5-oxathiadiazole 2-oxides was prepared and tested for antihyperglycemic activity in the db/db mouse, a model for type 2 (non-insulin dependent) diabetes mellitus. Substitution at the 1-, 5-, or 8-positions of the naphthalene ring with a halogen was found to be beneficial to antihyperglycemic activity. 4-[(5-Chloronaphthalen-2-yl)methyl]-3H-1,2,3,5-oxathiadiazole 2-oxide (45), one of the most potent compounds in this series, was selected for further pharmacological evaluation.

  DOI：

  10.1021/jm00069a006
• 作为产物：
  描述：

  1-甲氧基-2-萘甲醇 在 吡啶 、 氯化亚砜 作用下， 以 甲苯 为溶剂， 以98%的产率得到1-methoxy-2-(chloromethyl)naphthalene
  参考文献：
  名称：

  Synthesis of 2-Amido-2,3-dihydro-1H-phenalene Derivatives as New Conformationally Restricted Ligands for Melatonin Receptors

  摘要：

  Tetrahydroanthracene, tetrahydrophenanthrene, and tetrahydrophenalene moieties were used to design novel constrained melatoninergic agents. Compounds 1 and 2 were synthesized from the cyclization of the aryl succinic acids 6a,b followed by catalytic reduction, Curtius degradation to the amino derivatives, and acetylation. The phenalene derivatives 3 were prepared by cyclization of the aza lactones of the corresponding alpha-N-acetyl amino acids. The ketone derivatives were reduced directly by catalytic hydrogenation to produce the compounds 3. The different compounds were evaluated in vitro in binding assays using 2-[I-125]iodomelatonin and chicken brain membranes. Melatonin and 2-acetamido-8-methoxytetralin were used as the reference compounds. The results showed the superiority of the dihydrophenalene framework 3 over tho se of tetrahydro anthracene and tetrahydrophenanthrene. 3a had relatively good affinity for melatonin receptors (K-i = 28.7 nM). Introduction of an additional methoxy group gave a derivative (3c) with nanomolar affinity (K-i = 0.7 nM), confirming the existence of a secondary binding site in the receptor which has been described previously. An increase in the affinity was also observed with the propionamido derivative 3e (K-i = 6.0 nM). The potential agonist properties of the compound 3e were evaluated on the dermal melanocytes of Xenopus laevis tadpoles. At the concentration of 2.3 nM (5 x K-i), melatonin gave melanophore index value of 1. Similarly to melatonin, 3e was shown to be a potent agonist of the melanosome aggregation.

  DOI：

  10.1021/jm960219h

文献信息

• Amides tricycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
  申请人：ADIR ET COMPAGNIE

  公开号：EP0737670A1

  公开（公告）日：1996-10-16

  L'invention concerne les composés de formule (I) : dans laquelle R7, R8, Y, n et A sont tels que définis dans la description. Médicaments.

  本发明涉及式 (I) 化合物： 其中 R7、R8、Y、n 和 A 如说明书中所定义。 药物。
• COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS, METHOD OF SEPARATION, AND USE THEREOF
  申请人：Ustav organicke chemie a biochemie AV CR, v.v.i.

  公开号：EP3492460A1

  公开（公告）日：2019-06-05

  The present invention relates to the use of the compounds of general formula (I): wherein X, Y, Z, L, R and R1 are as described herein; for chromatographic separation of rare earth elements, as well as to the method of the separation of rare earth elements.

  本发明涉及通式（I）化合物的用途： 其中 X、Y、Z、L、R 和 R1 如本文所述； 以及分离稀土元素的方法。
• COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS AND S-, P-, D- METALS, METHOD OF SEPARATION, AND USE THEREOF
  申请人：Ustav Organicke Chemie a Biochemie AV CR, v.v.i.

  公开号：EP3717466A1

  公开（公告）日：2020-10-07
• US5712312A
  申请人：——

  公开号：US5712312A

  公开（公告）日：1998-01-27
• US5849781A
  申请人：——

  公开号：US5849781A

  公开（公告）日：1998-12-15